ADVERTISEMENT

COVID vaccines may not be available for commercial use this year

Published Jan 13, 2021 03:45 pm

Coronavirus vaccines may not yet be available for commercial use in the country this year.

According to Cabinet Secretary Karlo Nograles, people cannot yet buy the vaccine in the market since the emergency use authorization (EUA) to be given by the Food and Drug Administration (FDA) does not cover commercial use.

Cabinet Secretary Karlo Nograles
(PCOO / MANILA BULLETIN FILE PHOTO)

The government has so far secured millions of supplies from vaccine makers Covovax, Sinovac, and AstraZeneca, that are expected to be delivered to the county this year. Frontline health workers, seniors, poor citizens, and uniformed personnel will be among the priority beneficiaries of the government's free COVID-19 vaccines.

"Hindi po, dahil na-explain na ito ng FDA head natin, si Director General Domingo, na these vaccines because of the novelty ‘no, itong bagong bakuna na ito, mga bakuna that’s available, they apply for emergency use application dito sa bansa. And an EUA is actually not for commercial purposes (No, FDA head director general (Eric) Domingo has explained these vaccines, because of the novelty of these vaccines available, they apply for emergency use application in the country and an EUA is actually not for commercial purposes)," Nograles said during a televised press briefing Tuesday, when asked if the vaccines will be available in the market this year.

Given the limited vaccine supply that will be for emergency use, Nograles explained that any acquisition will go through the national government. He said local government units and the private sector could forge supply deals with the manufacturers but under a tripartite arrangement with the national government

"When the LGUs speak to the pharmaceutical companies, it’s also through a tripartite agreement with the national government na kasama doon sa tripartite agreement na iyan only because the unique characteristics of the vaccines that are available specifically for COVID-19 is an EUA application not just in the Philippines but in the entire world," he said.

"Lahat ng binibigay ng mga FDA ng iba’t ibang mga bansa is EUA (The FDAs in other countries give only EUA) and by the nature of the emergency use application, it is only through the national government. Why? Because, again, there is a limited number of vaccines available," he added.

Nograles said around 70 million Filipinos could be vaccinated under the programs initiated by the national government, local government, and the private sector. At least 75 billion will be set aside by the national government for the acquisition of the COVID-19 vaccines.

Of the 25 million COVID-19 vaccines developed by Sinovac, an initial 50,000 doses will be shipped to the country next month. The remaining supply will be delivered in the following months.

Pfizer, AstraZeneca, and Gamaleya have pending applications for EUA before the local drug regulators. Once the EUA is granted, the government can start to administer the drugs for its massive immunization drive.

ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.